Clinical Trial Update: Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing two dosing regimens of Eperisone (BID vs TID) for acute low back pain has completed, focusing on efficacy and safety outcomes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Eperisone (eperisone)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Low Back Pain | Phase 2 | Status: COMPLETED